Edesa Biotech Inc is a clinical-stage biopharmaceutical company focused on developing innovative therapies to address unmet medical needs in dermatology and immunology. The company's research and development efforts are centered around creating treatments for various skin disorders and autoimmune diseases, using its proprietary technology platforms. Edesa aims to bring forth new solutions through its dedication to scientific advancement and strong clinical trials, ultimately enhancing the quality of life for patients suffering from chronic conditions. Read More
Edesa Biotech said that data from a late-stage study of its experimental drug for the treatment of Acute Respiratory Distress Syndrome affirmed statistically significant mortality reductions.
